| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2880427 | The Annals of Thoracic Surgery | 2008 | 9 Pages |
Abstract
Recombinant activated factor VII appears to be effective in patients with refractory coagulopathy undergoing high-risk cardiovascular surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lyndsey J. Bowman, Walter E. Pharm D, Martha R. Stroud, Lydia R. Christiansen, John Lazarchick, Arthur J. MD, John M. MD, John M. MD, Fred A. MD, John S. MD, PhD,